> Shares of Germany's Schwarz Pharma were on the rise this morning on rumors of a potential takeover bid by Merck KGaA. Report
> Elan has licensed its NanoCrystal technology to Abbott and AstraZeneca for the development of new combinational therapies. Report
> Abbott Laboratories has teamed up with Fisher Scientific to collaborate on a drug discovery program using RNAi technology. Report
> Valera Pharmaceuticals has submitted an NDA for SUPPRELIN-LA, a therapy for the early onset of puberty in children. Report
> Texas A&M is launching a new project to develop genetically altered mice for research work as it develops a library of 350,000 "knockout" mice. Report
> King Pharmaceuticals and Wyeth Pharmaceuticals have revamped their marketing deal for Altace. Report
> Bayer has raised $1.5 billion to fund its acquisition of Schering-Plough. Article
> Actelion has gained a $7 million milestone payment from Merck for its rennin alliance. Report
> Medivir's Lipsovir has entered into a Phase III trial for labial herpes. Release
And Finally… A new study concludes that much wider use of a rapid flu test would vastly improve the diagnosis and treatment of influenza among children, helping prevent the spread of the disease. Article